SARS-CoV-2-IN-108
SARS-CoV-2-IN-108 (Compound 29) is an inhibitor for SARSCoV-2 papain-like protease with an IC50 of 0.14 µM. SARS-CoV-2-IN-108 inhibits the virus replication with an EC50 of 0.21 µM[1].
Product Specifications
UNSPSC
12352211
Target
SARS-CoV; Virus Protease
Type
Reference compound
Related Pathways
Anti-infection
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-108.html
Smiles
CCOC(/C=C/C(NNC(CCC1=C(C(N[C@H](C)C2=CC=CC(C3=CC=CS3)=C2)=O)C=CC=C1)=O)=O)=O
Molecular Formula
C28H29N3O5S
Molecular Weight
519.61
References & Citations
[1]Rouch CC, et al., Synthesis and Structure-Activity Relationship of Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease with Antiviral Potency. Bioorg Med Chem Lett. 2025 Feb 1;116:130034.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC403186 20 µg
Rapsyn (RAPSN) (NM_032645) Human Over-expression Lysate
Sign In for Pricing
View Details 
TRC-C991503-100MG 100 mg
3-(Cyclopropylcarbamoyl)phenylboronic Acid (>90%)
Sign In for Pricing
View Details